• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用 HEDIS 与调查标准定义持续性哮喘。

Persistent asthma defined using HEDIS versus survey criteria.

机构信息

Department of Allergy, Kaiser Permanente Medical Center, 7060 Clairemont Mesa Blvd, San Diego, CA 92111, USA.

出版信息

Am J Manag Care. 2010 Nov 1;16(11):e281-8.

PMID:21087074
Abstract

OBJECTIVES

To describe the relationships between persistent asthma defined by administrative versus survey data and their stability over time.

STUDY DESIGN

Longitudinal survey and retrospective administrative database.

METHODS

Administrative data were used to identify patients meeting the Healthcare Effectiveness Data and Information Set (HEDIS) criteria for persistent asthma in year 1 (2006). At the end of year 2 and on 3 occasions during year 3, patients were mailed a survey to define persistent asthma based on symptoms and medication use in the prior month and exacerbations in the prior 12 months. Administrative data were also used to define medical utilization for asthma in year 3.

RESULTS

Of 13,833 eligible patients, 2895 (20.9%) returned the survey; 2751 of these respondents reported physician-diagnosed asthma, of whom 2517 (91.5%) had survey-defined persistent asthma. Patients having survey-defined persistent asthma (68.0%) were more likely to requalify as having HEDIS-defined persistent asthma in year 2 than patients not having survey-defined persistent asthma (22.2%). However, 81.6% of survey respondents who did not requalify as having HEDIS-defined persistent asthma in year 2 had survey-defined persistent asthma. Patients with survey-defined persistent asthma in year 2 had significantly more medical utilization for asthma in year 3 than patients without survey-defined persistent asthma. Approximately 82% of the 799 patients completing all 4 surveys had persistent asthma on all surveys.

CONCLUSIONS

HEDIS-defined persistent asthma is generally consistent with survey-defined persistent asthma. Persistent asthma usually remains persistent over a 3-year period, indicating that it is a stable characteristic of asthma for most patients. The low survey response rate suggests that further population-based studies will be necessary to confirm the validity and generalizability of our study findings regarding persistent asthma.

摘要

目的

描述行政数据和调查数据定义的持续性哮喘之间的关系及其随时间的稳定性。

研究设计

纵向调查和回顾性行政数据库。

方法

行政数据用于确定符合医疗保健效果数据和信息集(HEDIS)标准的患者在第 1 年(2006 年)患有持续性哮喘。在第 2 年年末和第 3 年的 3 个时间点,通过邮寄调查来确定根据前 1 个月的症状和用药情况以及前 12 个月的加重情况定义持续性哮喘。还使用行政数据来确定第 3 年的哮喘医疗利用情况。

结果

在 13833 名合格患者中,有 2895 名(20.9%)返回了调查;在这些应答者中,有 2751 名报告了医生诊断的哮喘,其中 2517 名(91.5%)有调查定义的持续性哮喘。患有调查定义的持续性哮喘(68.0%)的患者在第 2 年重新符合 HEDIS 定义的持续性哮喘的可能性高于没有调查定义的持续性哮喘的患者(22.2%)。然而,81.6%的在第 2 年未重新符合 HEDIS 定义的持续性哮喘的调查应答者仍有调查定义的持续性哮喘。在第 2 年患有调查定义的持续性哮喘的患者在第 3 年的哮喘医疗利用显著高于没有调查定义的持续性哮喘的患者。在完成所有 4 次调查的 799 名患者中,约有 82%在所有调查中均有持续性哮喘。

结论

HEDIS 定义的持续性哮喘通常与调查定义的持续性哮喘一致。持续性哮喘通常在 3 年内保持持续性,表明它是大多数患者哮喘的一个稳定特征。低调查应答率表明,需要进一步进行基于人群的研究,以确认我们关于持续性哮喘的研究结果的有效性和普遍性。

相似文献

1
Persistent asthma defined using HEDIS versus survey criteria.使用 HEDIS 与调查标准定义持续性哮喘。
Am J Manag Care. 2010 Nov 1;16(11):e281-8.
2
How well do the HEDIS asthma inclusion criteria identify persistent asthma?医疗效果数据和信息集(HEDIS)哮喘纳入标准在识别持续性哮喘方面的效果如何?
Am J Manag Care. 2005 Oct;11(10):650-4.
3
[The clinicofunctional characterization of the phenotypes of severe uncontrollable bronchial asthma].
Klin Med (Mosk). 2006;84(2):24-7.
4
Association between previous health care use and initiation of inhaled corticosteroid and long-acting beta2-adrenergic agonist combination therapy among US patients with asthma.美国哮喘患者中既往医疗保健使用与吸入皮质类固醇和长效β2-肾上腺素能激动剂联合治疗起始的相关性。
Clin Ther. 2009 Nov;31(11):2574-83. doi: 10.1016/j.clinthera.2009.11.007.
5
New trends in treating chronic persistent asthma in adults.成人慢性持续性哮喘治疗的新趋势。
West J Med. 1992 Jan;156(1):66.
6
Asthma in primary care.基层医疗中的哮喘
J Med Liban. 2001 Sep-Oct;49(5):284-7.
7
Limits of the HEDIS criteria in determining asthma severity for children.健康维护组织效果指标系统(HEDIS)标准在判定儿童哮喘严重程度方面的局限性。
Pediatrics. 2004 Oct;114(4):1049-55. doi: 10.1542/peds.2003-1162-L.
8
Impact of asthma control on sleep, attendance at work, normal activities, and disease burden.哮喘控制对睡眠、工作出勤、正常活动和疾病负担的影响。
Ann Allergy Asthma Immunol. 2010 Aug;105(2):118-23. doi: 10.1016/j.anai.2010.05.009. Epub 2010 Jul 1.
9
Investigation and treatment of asthma.
J Med Assoc Thai. 2005 Sep;88 Suppl 4:S363-8.
10
[Beta-2 adrenergic receptor agonists in asthma treatment].
Duodecim. 1995;111(8):744-8.

引用本文的文献

1
Risk factors for bronchiolitis obliterans development in children after Mycoplasma pneumoniae pneumonia: a retrospective study of 981 patients.肺炎支原体肺炎后儿童闭塞性细支气管炎发生的危险因素:一项对981例患者的回顾性研究
Ital J Pediatr. 2025 Mar 31;51(1):105. doi: 10.1186/s13052-025-01932-w.
2
A Roadmap for Using Causal Inference and Machine Learning to Personalize Asthma Medication Selection.使用因果推断和机器学习实现哮喘药物个性化选择的路线图。
JMIR Med Inform. 2024 Apr 17;12:e56572. doi: 10.2196/56572.
3
Asthma Quality Measurement and Adverse Outcomes in Medicaid-Enrolled Children.
医疗保险覆盖儿童哮喘质量测量与不良结局
Pediatrics. 2023 Aug 1;152(2). doi: 10.1542/peds.2022-059812.
4
Self-Reported Physical Activity and Asthma Risk in Children.儿童自述体力活动与哮喘风险。
J Allergy Clin Immunol Pract. 2022 Jan;10(1):231-239.e3. doi: 10.1016/j.jaip.2021.08.040. Epub 2021 Sep 16.
5
Pilot study of a brief provider and EMR-based intervention for overweight teens with asthma.针对超重哮喘青少年的基于医疗服务提供者和电子病历的简短干预的初步研究。
Pilot Feasibility Stud. 2021 Aug 30;7(1):167. doi: 10.1186/s40814-021-00848-6.
6
Complications and Health Care Resource Utilization Associated with Systemic Corticosteroids in Children and Adolescents with Persistent Asthma.儿童和青少年持续性哮喘患者全身使用皮质类固醇的并发症和医疗资源利用情况。
J Allergy Clin Immunol Pract. 2021 Apr;9(4):1541-1551.e9. doi: 10.1016/j.jaip.2020.11.049. Epub 2020 Dec 5.
7
Participant-level characteristics differ by recruitment setting when evaluating a behavioral intervention targeting adolescents with asthma.当评估一项针对哮喘青少年的行为干预措施时,参与者的特征因招募环境而异。
J Asthma. 2021 Mar;58(3):370-377. doi: 10.1080/02770903.2019.1690661. Epub 2019 Nov 22.
8
Trends and Disparities in Asthma Biologic Use in the United States.美国哮喘生物制剂使用的趋势和差异。
J Allergy Clin Immunol Pract. 2020 Feb;8(2):549-554.e1. doi: 10.1016/j.jaip.2019.08.024. Epub 2019 Aug 28.
9
Identifying Asthma Exacerbation-Related Emergency Department Visit Using Electronic Medical Record and Claims Data.利用电子病历和理赔数据识别与哮喘急性加重相关的急诊科就诊情况。
Appl Clin Inform. 2018 Jul;9(3):528-540. doi: 10.1055/s-0038-1666994. Epub 2018 Jul 18.
10
Systematic review of atopic dermatitis disease definition in studies using routinely collected health data.系统评价使用常规收集健康数据的研究中特应性皮炎疾病定义。
Br J Dermatol. 2018 Jun;178(6):1280-1287. doi: 10.1111/bjd.16340. Epub 2018 Apr 25.